Ibandronate oral/injection

Generic name: Ibandronate (oral/injection)
Drug class: Bisphosphonates

Usage of Ibandronate oral/injection

Ibandronate is a bisphosphonate (bis FOS fo nayt) medicine that alters bone formation and breakdown in the body. This can slow bone loss and may help prevent bone fractures.

Ibandronate is used to treat or prevent osteoporosis in women after menopause.

Ibandronate may also be used for purposes not listed in this medication guide.

Ibandronate oral/injection side effects

Get emergency medical help if you have signs of an allergic Reaction: hives; wheezing, difficult breathing; swelling of your face, lips, tongue, or throat.

Ibandronate may cause serious side effects. Stop using ibandronate and call your doctor at once if you have:

chest pain, new or worsening heartburn;

difficulty or pain when swallowing;

pain or burning under the ribs or in the back;

severe heartburn, burning pain in your upper stomach, or coughing up blood;

new or unusual pain in your thigh or hip;

jaw pain, numbness, or swelling;

severe joint, bone, or muscle pain; or

low calcium levels--muscle spasms or contractions, numbness or tingly feeling (around your mouth, or in your fingers and toes).

Common side effects of ibandronate may include:

heartburn, stomach pain, diarrhea;

back pain, bone pain, muscle or joint pain;

pain in your arms or legs;

headache; or

fever, chills, tiredness, flu-like symptoms.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Ibandronate oral/injection

You should not use ibandronate if you are allergic to it, or if you have:

severe kidney disease; or

low blood levels of calcium (hypocalcemia).

Do not take an ibandronate tablet if you have problems with your esophagus, or if you cannot sit upright or stand for at least 60 minutes. Ibandronate can cause serious problems in the stomach or esophagus. You must stay upright for at least 1 full hour after taking ibandronate.

To make sure ibandronate is safe for you, tell your doctor if you have ever HAD:

trouble swallowing;

problems with your stomach or digestion;

hypocalcemia;

a dental problem (you may need a dental exam before you begin using ibandronate);

kidney disease; or

any condition that makes it hard for your body to absorb nutrients from food (malabsorption).

In rare cases, this medicine may cause bone loss (osteonecrosis) in the jaw. Symptoms include jaw pain or numbness, red or swollen gums, loose teeth, or slow healing after dental work. The longer you use ibandronate, the more likely you are to develop this condition.

Osteonecrosis of the jaw may be more likely if you have cancer or received chemotherapy, radiation, or steroids. Other risk factors include blood clotting disorders, anemia (low red blood cells), and a pre existing dental problem.

Talk with your doctor about the risks and benefits of using this medication.

It is not known whether ibandronate will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether ibandronate passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Relate drugs

How to use Ibandronate oral/injection

Usual Adult Dose for Osteoporosis:

Oral:150 mg orally once a month on the SAMe day each monthIV Injection:3 mg by IV injection over 15 to 30 seconds every three months.Comments:-The IV injection should not be administered more frequently than once every 3 months.-Obtain serum creatinine prior administration of each IV injection.-Perform a routine oral examination prior administration of IV injectionUses: Treatment and prevention of postmenopausal osteoporosis, to increase bone mineral density (BMD) and to reduce the incidence of vertebral fractures

Usual Adult Dose for Prevention of Osteoporosis:

Oral:150 mg orally once a month on the same day each monthIV Injection:3 mg by IV injection over 15 to 30 seconds every three months.Comments:-The IV injection should not be administered more frequently than once every 3 months.-Obtain serum creatinine prior administration of each IV injection.-Perform a routine oral examination prior administration of IV injectionUses: Treatment and prevention of postmenopausal osteoporosis, to increase bone mineral density (BMD) and to reduce the incidence of vertebral fractures

Warnings

You should not use ibandronate if you have severe kidney disease or low levels of calcium in your blood.

Do not take an ibandronate tablet if you have problems with your esophagus, or if you cannot sit upright or stand for at least 60 minutes after taking the tablet.

Ibandronate tablets can cause serious problems in the stomach or esophagus. Stop taking ibandronate and call your doctor at once if you have chest pain, new or worsening heartburn, or pain when swallowing.

Also call your doctor if you have muscle spasms, numbness or tingling (in hands and feet or around the mouth), new or unusual hip pain, or severe pain in your joints, bones, or muscles.

What other drugs will affect Ibandronate oral/injection

Tell your doctor about all your current medicines and any you start or stop using, especially:

aspirin; or

NSAIDs (nonsteroidal anti-inflammatory drugs)--ibuprofen (Advil, Motrin), Naproxen (Aleve), Celecoxib, diclofeNAC, Indomethacin, Meloxicam, and others.

This list is not complete. Other drugs may interact with ibandronate, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Talk with your doctor about the best dosing schedule for your other medicines.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.